Skip to content
value.today

Orchestra BioMed Holdings, Inc.: insider trading

195 trades by 24 directors, officers and 10% owners since 2020, from their SEC Form 4 and 5 filings.

Bought, 12 months
$6.4 M
13 purchases by 7 insiders
Sold, 12 months
$439 K
7 sales by 2 insiders
Bought, 3 months
$6.2 M
7 purchases
Sold, 3 months
$256 K
3 sales

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$6.1 M-$226 K$0May 2024: bought $28 K (1 trades), sold $0 (0 trades)May 24Jun 2024: bought $7 K (1 trades), sold $0 (0 trades)Aug 2024: bought $15 K (1 trades), sold $0 (0 trades)Sep 2024: bought $48 K (5 trades), sold $226 K (8 trades)SepDec 2024: bought $48 K (3 trades), sold $0 (0 trades)Apr 2025: bought $276 K (2 trades), sold $0 (0 trades)Jun 2025: bought $0 (0 trades), sold $8 K (1 trades)JunAug 2025: bought $2.0 M (6 trades), sold $0 (0 trades)Sep 2025: bought $2 K (1 trades), sold $0 (0 trades)Nov 2025: bought $20 K (1 trades), sold $0 (0 trades)NovMar 2026: bought $43 K (1 trades), sold $0 (0 trades)Apr 2026: bought $0 (0 trades), sold $132 (1 trades)May 2026: bought $139 K (4 trades), sold $0 (0 trades)MayJun 2026: bought $19 K (1 trades), sold $58 K (1 trades)Jul 2026: bought $0 (0 trades), sold $64 K (1 trades)Aug 2026: bought $11 K (1 trades), sold $61 K (1 trades)AugSep 2026: bought $48 K (1 trades), sold $74 K (1 trades)Oct 2026: bought $0 (0 trades), sold $95 K (1 trades)Nov 2026: bought $6.1 M (5 trades), sold $86 K (1 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (24)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Orchestra BioMed Holdings, Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Andrew Lawrence TaylorChief Financial Officer590,989$5 K—
David P. HochmanSee Remarks, Director1.07 M$154 K—
David PacittiDirector74,750$100 K—
Eric S. FainDirector7,500$83 K—
RTW Investments, LP10% owner—$6.0 M$132
Darren ShermanSee Remarks, Director1.10 M$11 K$439 K
Joshua AielloPrincipal Accounting Officer18,441——
Chris ClearyDirector29,153——
John Prosper MackDirector66,544——
Pamela Ann ConnealyDirector66,038——
Jason AryehDirector118,118$37 K—
Perceptive Life Sciences Master Fund LTD10% owner———
Roderick Wong10% owner———
HSAC 2 Holdings, LLC10% owner1.71 M——
Eric A. RoseDirector7,544——
William Reed LittleSee Remarks307,859——
George PapandreouSee Remarks42,000——
Yuval MikaSee Remarks158,905——
Geoffrey Wade SmithDirector20,913——
Medtronic plc10% owner———
Connealy Pamela YanchikDirector4,246——
Michael KaswanChief Financial Officer162,574——
Alice LeeVP Operations, Sec & Treasurer10,000——
Stephanie A. SirotaVP of Corp Stratege and Comm———

Trades#

Orchestra BioMed Holdings, Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed RTW Investments, LP10% ownerBuyindirect+1.20 M$5.000$6.0 M10.76 MForm 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+5,000$5.000$25 K437,916Form 4
filed David PacittiDirectorBuy+20,000$5.000$100 K74,750Form 4
filed Andrew Lawrence TaylorChief Financial OfficerBuy+1,000$5.000$5 K590,989Form 4
filed Eric S. FainDirectorBuyindirect+20,000$5.000—119,630Form 4
filed David P. HochmanSee Remarks, DirectorBuy+10,000$4.790$48 K1.07 MForm 4
filed Darren ShermanSee Remarks, DirectorBuyindirect+2,000$5.330$11 K2,000Form 4
filed David P. HochmanSee Remarks, DirectorBuy+5,000$3.830$19 K1.06 MForm 4
filed Jason AryehDirectorBuy+665$3.750$2 K118,118Form 4
filed Jason AryehDirectorBuy+8,971$3.900$35 K117,453Form 4
filed David P. HochmanSee Remarks, DirectorBuy+5,000$3.770$19 K1.06 MForm 4
filed Eric S. FainDirectorBuyindirect+20,000$4.130$83 K91,709Form 4
filed David P. HochmanSee Remarks, DirectorBuy+10,000$4.290$43 K1.09 MForm 4
filed David P. HochmanSee Remarks, DirectorBuy+5,000$4.070$20 K612,822Form 4
filed Jason AryehDirectorBuy+1,000$2.450$2 K108,482Form 4
filed Andrew Lawrence TaylorChief Financial OfficerBuy+2,000$2.550$5 K482,788Form 4
filed Darren ShermanSee Remarks, DirectorBuy+3,000$2.620$8 K926,837Form 4
filed Eric S. FainDirectorBuyindirect+5,760$2.610$15 K71,709Form 4
filed David P. HochmanSee Remarks, DirectorBuy+6,000$2.490$15 K651,460Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+20,000$2.750$55 K349,331Form 4
filed Perceptive Life Sciences Master Fund LTD10% ownerBuyindirect+700,000$2.750$1.9 M5.29 MForm 4
filed Roderick Wong10% ownerBuyindirect+49,900$2.990$149 K8.31 MForm 4
filed RTW Investments, LP10% ownerBuyindirect+50,000$2.530$127 K8.26 MForm 4
filed David P. HochmanSee Remarks, DirectorBuy+4,000$4.660$19 K579,498Form 4
filed Andrew Lawrence TaylorChief Financial OfficerBuy+1,000$4.830$5 K344,960Form 4
filed David P. HochmanSee Remarks, DirectorBuy+5,000$4.910$25 K575,498Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+1,500$4.860$7 K335,002Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+2,000$4.740$9 K2,000Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+2,000$4.700$9 K2,000Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+2,000$4.730$9 K2,000Form 4
filed David P. HochmanSee Remarks, DirectorBuy+2,500$4.910$12 K570,498Form 4
filed David P. HochmanSee Remarks, DirectorBuy+2,500$5.840$15 K567,998Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect+1,000$6.950$7 K333,502Form 4
filed William Reed LittleSee RemarksBuy+4,000$7.000$28 K307,859Form 4
filed David P. HochmanSee Remarks, DirectorBuyindirect · amended+3,000$5.150$15 K332,502Form 4/A
filed David P. HochmanSee Remarks, DirectorBuyindirect · amended+2,000$4.750$10 K329,502Form 4/A
filed Medtronic plc10% ownerBuyindirect+6,835$9.280$63 K5.00 MForm 4
filed Roderick WongChief Executive Officer, Director, 10% ownerBuyindirect+1.81 M$10.00$18.1 M2.81 MForm 4
filed Roderick WongChief Executive Officer, DirectorBuyindirect+1.00 M$10.01$10.0 M1.00 MForm 4
filed HSAC 2 Holdings, LLC10% ownerBuy+450,000$10.00$4.5 M4.36 MForm 4
filed Alice LeeVP Operations, Sec & TreasurerBuy+10,000$10.00$100 K10,000Form 4
filed Stephanie A. SirotaVP of Corp Stratege and CommBuyindirect+20,000$10.00$200 K20,000Form 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice